urapidil has been researched along with Hypercholesterolemia in 1 studies
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
Excerpt | Relevance | Reference |
---|---|---|
" In the light of recent evidence that some antihypertensive drugs with alpha-1 blocking properties reduce blood pressure (BP) and total cholesterol (chol), increasing chol content in the non-atherogenic high density lipoproteins (HDL-chol), the effects of urapidil, a peripheral alpha-1 adrenoceptor antagonist, with a central action component on BP and plasma lipids were evaluated in 49 mild, hypertensive patients with mild to moderately severe hypercholesterolemia (serum chol 220-320 mg/dl) for a 6 month period in a double-blind randomized study versus placebo." | 5.07 | Urapidil in hypercholesterolemic hypertensive patients. ( Ferrara, LA; Fogari, R; Leonetti, G; Mancini, M; Mazzola, C; Zanchetti, A, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferrara, LA | 1 |
Leonetti, G | 1 |
Fogari, R | 1 |
Mazzola, C | 1 |
Mancini, M | 1 |
Zanchetti, A | 1 |
1 trial available for urapidil and Hypercholesterolemia
Article | Year |
---|---|
Urapidil in hypercholesterolemic hypertensive patients.
Topics: Antihypertensive Agents; Female; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Ag | 1994 |